Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population (CAPABLE)

Viatris

Status and phase: Completed; Phase 4

Conditions: Hypertension; Dyslipidemia

Treatments: Drug: Amlodipine/Atorvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00150384

A3841025

Details and patient eligibility

About

The purpose is to demonstrate the utility of Caduet (amlodipine/atorvastatin) in the African American population

Sex: All

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• African American men and women with concurrent hypertension and dyslipidemia that is either treated or untreated
• Subjects must satisfy the blood pressure and LDL-C inclusion criteria for their respective Cardiovascular Risk group determined at screening

Exclusion criteria

• Subjects currently being treated with concomitant amlodipine and atorvastatin therapy, including Caduet
• Subjects with blood pressure at goal

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)